Use of Human Embryonic Stem Cells in the Treatment of Thrombocytopenia: a Case Series.

“Treatment options such as corticosteroids, immunoglobulins medicines, blood or platelet transfusions, or splenectomy are used for thrombocytopenia patients. In the present study, we reported the safety and efficacy of human embryonic stem cell (hESC) therapy in two patients with thrombocytopenia. The patients were presented with general weakness and were unable to do their routine work. After the laboratory examinations, it was confirmed that both the patients were suffering from thrombocytopenia having platelet count 0.70m3 and 0.80m3, respectively.
hESC therapy was found to be safe and effective. The study concluded that hESC therapy improved the condition of patients with thrombocytopenia.”